Biology Reference
In-Depth Information
7. Reid T, Galanis E, Abbruzzese J, Sze D,
Andrews J, Romel L, Hatfi eld M, Rubin J, Kirn
D (2001) Intra-arterial administration of a rep-
lication-selective adenovirus (dl1520) in patients
with colorectal carcinoma metastatic to the liver:
a phase I trial. Gene Ther 8:1618-1626
8. Crystal RG, Harvey BG, Wisnivesky JP,
O'Donoghue KA, Chu KW, Maroni J, Muscat
JC, Pippo AL, Wright CE, Kaner RJ et al (2002)
Analysis of risk factors for local delivery of low-
and intermediate-dose adenovirus gene transfer
vectors to individuals with a spectrum of comor-
bid conditions. Hum Gene Ther 13:65-100
9. Ben-Gary H, McKinney RL, Rosengart T,
Lesser ML, Crystal RG (2002) Systemic inter-
leukin-6 responses following administration of
adenovirus gene transfer vectors to humans by
different routes. Mol Ther 6:287-297
10. Mickelson CA (2000) Department of Health
and Human Services, National Institutes of
Health Recombinant DNA Advisory
Committee. Minutes of meeting March 8-10,
2000. Hum Gene Ther 11:2159-2192
11. McCoy RD, Davidson BL, Roessler BJ,
Huffnagle GB, Janich SL, Laing TJ, Simon
RH (1995) Pulmonary infl ammation induced
by incomplete or inactivated adenoviral parti-
cles. Hum Gene Ther 6:1553-1560
12. Muruve DA, Barnes MJ, Stillman IE,
Libermann TA (1999) Adenoviral gene ther-
apy leads to rapid induction of multiple che-
mokines and acute neutrophil-dependent
hepatic injury in vivo. Hum Gene Ther
10:965-976
13. Doronin K, Flatt JW, Di Paolo NC, Khare R,
Kalyuzhniy O, Acchione M, Sumida JP, Ohto
U, Shimizu T, Akashi-Takamura S et al (2012)
Coagulation factor X activates innate immu-
nity to human species C adenovirus. Science
338:795-798
